4SC AG/ DE000A14KL72 /
| 9/18/2020 8:00:47 AM | Chg. -0.015 | Volume | Bid6:06:29 PM | Ask6:06:29 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.745EUR | -0.85% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 83.9 mill.EUR | 0.00% | - |
pressetext
9/15
PTA-News: 4SC AG: 4SC expands avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfiz...
pressetext
9/11
PTA-News: 4SC AG: 4SC and Maruho Discontinue Collaboration for Development of 4SC's Kv1.3 Inhibitors
pressetext
8/4
PTA-News: 4SC AG: Conference call to be hosted on 11 August 2020 to present the half-year report 202...
GlobeNewswire
4/1/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
6/11/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018